Omega-3-carboxylic acids Active Not Recruiting Phase 3 Trials for Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02104817Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia